Ridinilazole for Clostridium difficile Infection: Human Gut Microbiome Profiles from a Phase 2 Clinical Trial

Ridinilazole for Clostridium difficile Infection: Human Gut Microbiome Profiles from a Phase 2 Clinical Trial